-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Fulcrum Therapeutics, Raises Price Target to $10

Benzinga·12/08/2025 14:35:23
Listen to the news
RBC Capital analyst Luca Issi maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Sector Perform and raises the price target from $7 to $10.